Skip to main content
Fig. 12 | AAPS Open

Fig. 12

From: Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection

Fig. 12

The concentration time profiles of Pep-ADC and unconjugated mAb3. Plasma was collected at indicated time points over 14 days following a single 3 mg/kg IV administration of DyLight 650-labeled Pep-ADC or DyLight 650-labeled unconjugated mAb3 in normal C57BL/6 J mice, and the concentrations were determined by fluorescence emission-linked assays. Data plotted are mean from two mice per time point. Error bars correspond to the range. Error bars smaller than the symbols are not plotted

Back to article page